Figure 1 | Scientific Reports

Figure 1

From: Performance evaluation of newly developed surrogate virus neutralization tests for detecting neutralizing antibodies against SARS-CoV-2

Figure 1

Receiver-Operating Characteristic analysis for detecting NAbs of SARS-CoV-2 of (a) VERI-Q SARS-CoV-2 Neutralizing Antibody Detection ELISA Kit (eCoV-CN) and (b) VERI-Q SARS-CoV-2 Neutralizing Antibody Rapid Test Kit (rCoV-RN). The optimal cut-off values for %-inhibition of eCoV-CN and P ratio of rCoV-RN obtained from the analysis were 30% and 0.83, respectively.

Back to article page